Jazz Pharmaceuticals plc Cash Conversion Cycle 2011-2026 | JAZZ

Annual Cash Conversion Cycle Jazz Pharmaceuticals plc

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
66.2	63.8	64.6	60.6	56.6	58.1	149	88	113	98	49.6	73.2	79.7	96.4	14.6

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
149	14.6	75.4

Quarterly Cash Conversion Cycle Jazz Pharmaceuticals plc

2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
59.9	59.6	70	61.5	62.6	67.5	58.1	58.8	65.2	-	29.2	28	63.7	-	54.8	55.9	60.9	54.4	60.2	64.3	64.2	55.8	60.4	60.8	55.6	50.5	51.3	48.1	50.1	46.9	49.7	51.9	55.6	53.9	57.1	56.1	60.3	56.1	56.1	57.3	58.4	51.8	55.5	58.4	57.5	48.3	49	54.7	46.6	37.5	39.2	55.4	48.9	37.5	42.8	48.6	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
70	28	54.1

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
I-Mab IMAB	-1.97 K	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
Apellis Pharmaceuticals APLS	115	$ 20.7	-1.24 %	$ 2.61 B	USA
Aptorum Group Limited APM	-400	$ 0.84	7.59 %	$ 4.58 M	China
Axsome Therapeutics AXSM	-256	$ 166.38	1.52 %	$ 8.28 B	USA
AbCellera Biologics ABCL	173	$ 3.82	5.82 %	$ 1.14 B	Canada
EyeGate Pharmaceuticals, Inc. EYEG	17	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	82.8	-	-18.52 %	$ 27.3 M	Britain
Codexis CDXS	-48.2	$ 1.02	0.99 %	$ 74.9 M	USA
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Cellectis S.A. CLLS	-839	$ 3.8	-2.06 %	$ 116 M	France
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
Acorda Therapeutics ACOR	117	-	-24.86 %	$ 820 K	USA
Collegium Pharmaceutical COLL	537	$ 41.6	-0.17 %	$ 1.32 B	USA
Corcept Therapeutics Incorporated CORT	-402	$ 35.97	0.76 %	$ 3.74 B	USA
Catalyst Pharmaceuticals CPRX	120	$ 23.88	3.47 %	$ 2.92 B	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Curis CRIS	103	$ 1.08	-5.26 %	$ 6.81 M	USA
Crinetics Pharmaceuticals CRNX	-4.27 K	$ 40.68	-1.02 %	$ 3.83 B	USA
Champions Oncology CSBR	1.94	$ 6.07	2.71 %	$ 82.9 M	USA
Aeterna Zentaris AEZS	-34.3 K	-	5.93 %	$ 314 M	Canada
DBV Technologies S.A. DBVT	71.3	$ 23.25	10.77 %	$ 2.26 B	France
AgeX Therapeutics AGE	-8.96 K	-	-10.17 %	$ 12.2 K	USA
Precision BioSciences DTIL	6.07	$ 4.33	3.1 %	$ 16.6 M	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Agenus AGEN	-6 K	$ 3.34	0.3 %	$ 1.2 M	USA
Dyadic International DYAI	-128	$ 0.77	-1.68 %	$ 22.2 M	USA
Ayala Pharmaceuticals AYLA	-2.15 K	-	-	$ 7.46 M	Israel
Editas Medicine EDIT	149	$ 2.15	-2.27 %	$ 177 M	USA
Edesa Biotech EDSA	97.1	$ 2.28	3.64 %	$ 7.29 M	USA
Agios Pharmaceuticals AGIO	735	$ 29.2	-3.41 %	$ 1.69 B	USA
Advaxis ADXS	-143 K	-	-9.65 %	$ 45.9 M	USA
Equillium EQ	33.2	$ 1.92	5.49 %	$ 66.7 M	USA